In this study, we hypothesized that QQc would restore the functions of human PbMNCs derived from patients with diabetes and therapy with the MNC‐QQ cells (monocytes, CD34+, and lymphocytes) would demonstrate vasculogenic, anti‐inflammatory, and wound‐healing potential in diabetic patients with ischemic disease and non‐healing wounds. The gene discussed is CD34; the disease is diabetes mellitus.